Current pharmacotherapy options for gastritis

Bibliography

• Hojgaard L, Matzen P, Christoffersen P. Gastritis–a clinical entity? Scand J Gastroenterol Suppl 1987;128:90-3
   PubMedGoogle Scholar
• Redeen S, Petersson F, Jonsson KA, Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy 2003;35:946-50
   PubMed Web of Science ®Google Scholar
• Calabrese C, Di Febo G, Brandi G, Correlation between endoscopic features of gastric antrum, histology and Helicobacter pylori infection in adults. Ital J Gastroenterol Hepatol 1999;31:359-65
   PubMedGoogle Scholar
• Loffeld RJ. Diagnostic value of endoscopic signs of gastritis: with special emphasis to nodular antritis. Neth J Med 1999;54:96-100
   PubMed Web of Science ®Google Scholar
• Yela MC, Manzano ML, Rodriguez-Munoz S, Assessment of the usefulness of endoscopic signs in Helicobacter pylori associated gastritis. Rev Esp Enferm Dig 1997;89:3-12
   PubMed Web of Science ®Google Scholar
• Yagi K, Honda H, Yang JM, Magnifying endoscopy in gastritis of the corpus. Endoscopy 2005;37:660-6
   PubMed Web of Science ®Google Scholar
• Sipponen P, Price AB. The sydney system for classification of gastritis 20 years ago. J Gastroenterol Hepatol 2011;26(Suppl 1):31-4
   PubMedGoogle Scholar
• Dixon MF, Genta RM, Yardley JH, Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81
   PubMed Web of Science ®Google Scholar
• Rugge M, Meggio A, Pennelli G, Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631-6
   PubMed Web of Science ®Google Scholar
• Rugge M, Pennelli G, Pilozzi E, Gastritis: the histology report. Dig Liver Dis 2011;43(Suppl 4):S373-84
   Google Scholar
• Capelle LG, de Vries AC, Haringsma J, The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71:1150-8
   PubMed Web of Science ®Google Scholar
• Rugge M, Fassan M, Pizzi M, Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011;17:4596-601
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Areia M, de Vries AC, Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94
   PubMed Web of Science ®Google Scholar
• Sipponen P. Chronic gastritis in former times and now. Helicobacter 2007;12(Suppl 2):16-21
   PubMedGoogle Scholar
• McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597-604
   PubMed Web of Science ®Google Scholar
• Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90
   PubMed Web of Science ®Google Scholar
• Post PN, Kuipers EJ, Meijer GA. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 2006;23:1587-93
   PubMed Web of Science ®Google Scholar
• de Vries AC, Meijer GA, Looman CW, Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007;56:1665-70
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86
   PubMed Web of Science ®Google Scholar
• den Hoed CM, Vila AJ, Holster IL, Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter 2011;16:405-9
   PubMed Web of Science ®Google Scholar
• Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996;10(Suppl 1):29-37
   PubMed Web of Science ®Google Scholar
• Lauwers GY, Fujita H, Nagata K, Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol 2010;45:131-45
   PubMed Web of Science ®Google Scholar
• D'Elios MM, Appelmelk BJ, Amedei A, Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 2004;10:316-23
   PubMed Web of Science ®Google Scholar
• Veijola LI, Oksanen AM, Sipponen PI, Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol 2010;16:83-8
   PubMed Web of Science ®Google Scholar
• Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995;108:917-24
   PubMed Web of Science ®Google Scholar
• Niemela S. Duodenogastric reflux in patients with upper abdominal complaints or gastric ulcer with particular reference to reflux-associated gastritis. Scand J Gastroenterol 1985;115(Suppl):1-56
   Google Scholar
• Chen H, Li X, Ge Z, Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy. Can J Gastroenterol 2010;24:197-201
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Adult eosinophilic gastroenteritis and hypereosinophilic syndromes. World J Gastroenterol 2008;14:6771-3
   PubMed Web of Science ®Google Scholar
• Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets. Eur J Gastroenterol Hepatol 2001;13:425-7
   PubMed Web of Science ®Google Scholar
• Madisch A, Miehlke S, Neuber F, Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy–a randomized, double-blind, placebo-controlled multicentre trial. Aliment Pharmacol Ther 2006;23:473-9
   PubMed Web of Science ®Google Scholar
• Selgrad M, Kandulski A, Malfertheiner P. Dyspepsia and Helicobacter pylori. Dig Dis 2008;26:210-14
   PubMed Web of Science ®Google Scholar
• Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;134:361-9
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Soo S, Deeks J, Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;CD002096
   Google Scholar
• Marshall BJ, Goodwin CS, Warren JR, Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansen S, Rodriguez L, Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71
   PubMed Web of Science ®Google Scholar
• Capelle LG, de Vries AC, Looman CW, Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008;44:2470-6
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Cristofari F, Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010;8:105-10
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O'Morain CA, Management of Helicobacter pylori infection – the Maastricht IV/Florence consensus report. Gut 2012;61:646-64
   PubMed Web of Science ®Google Scholar
• Valle J, Seppala K, Sipponen P, Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 1991;26:1057-65
   PubMed Web of Science ®Google Scholar
• Malfertheiner P. Gastric atrophy reversible or irreversible after Helicobacter pylori eradication - an open question. Digestion 2011;83:250-2
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12-20
   PubMed Web of Science ®Google Scholar
• Wang J, Xu L, Shi R, Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011;83:253-60
   PubMed Web of Science ®Google Scholar
• Rokkas T, Pistiolas D, Sechopoulos P, The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007;12(Suppl 2):32-8
   PubMed Web of Science ®Google Scholar
• De Vries AC, Kuipers EJ. Review article: helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007;26(Suppl 2):25-35
   PubMedGoogle Scholar
• Fuccio L, Zagari RM, Eusebi LH, Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-8
   PubMed Web of Science ®Google Scholar
• de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol 2009;104:1342-5
   PubMed Web of Science ®Google Scholar
• Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53
   PubMed Web of Science ®Google Scholar
• Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998;115:1272-7
   PubMed Web of Science ®Google Scholar
• Romano M, Iovene MR, Russo MI, Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J Clin Pathol 2008;61:1112-15
   PubMed Web of Science ®Google Scholar
• Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007;20:280-322
   PubMed Web of Science ®Google Scholar
• Occhialini A, Urdaci M, Doucet-Populaire F, Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997;41:2724-8
   PubMed Web of Science ®Google Scholar
• Megraud F, Coenen S, Versporten A, Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2012; Epub ahead of print
   Web of Science ®Google Scholar
• De Francesco V, Giorgio F, Hassan C, Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010;19:409-14
   PubMed Web of Science ®Google Scholar
• Furuta T, Graham DY. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am 2010;39:465-80
   PubMed Web of Science ®Google Scholar
• Hunfeld NG, Touw DJ, Mathot RA, A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism. Aliment Pharmacol Ther 2010;31:150-9
   PubMed Web of Science ®Google Scholar
• Padol S, Yuan Y, Thabane M, The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol 2006;101:1467-75
   PubMed Web of Science ®Google Scholar
• Serrano DR, Torrado S, Torrado-Santiago S, The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments. Curr Drug Metab 2012; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Furuta T, Shirai N, Kodaira M, Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori. Clin Pharmacol Ther 2007;81:521-8
   PubMed Web of Science ®Google Scholar
• Chey WD, Wong BC; Practice Parameters Committee of the American College of G. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25
   PubMed Web of Science ®Google Scholar
• Fock KM, Katelaris P, Sugano K, Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600
   PubMed Web of Science ®Google Scholar
• Vakil N. Helicobacter pylori: factors affecting eradication and recurrence. Am J Gastroenterol 2005;100:2393-4
   PubMed Web of Science ®Google Scholar
• Vallve M, Vergara M, Gisbert JP, Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Ther 2002;16:1149-56
   PubMed Web of Science ®Google Scholar
• Fuccio L, Minardi ME, Zagari RM, Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007;147:553-62
   PubMed Web of Science ®Google Scholar
• Megraud F. The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. Therap Adv Gastroenterol 2012;5:103-9
   PubMed Web of Science ®Google Scholar
• Ford AC, Malfertheiner P, Giguere M, Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World J Gastroenterol 2008;14:7361-70
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clin Exp Gastroenterol 2012;5:23-34
   PubMedGoogle Scholar
• Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 2007;26:343-57
   PubMed Web of Science ®Google Scholar
• Luther J, Higgins PD, Schoenfeld PS, Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol 2010;105:65-73
   PubMed Web of Science ®Google Scholar
• Zullo A, Rinaldi V, Winn S, A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:715-18
   PubMed Web of Science ®Google Scholar
• Luther J, Chey WD. Sequential therapy for Helicobacter pylori: a two for one deal that's worth the extra effort? Gastroenterology 2009;136:720-2
   PubMedGoogle Scholar
• Gisbert JP, Calvet X, O'Connor A, Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol 2010;44:313-25
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Calvet X, O'Connor JP, The sequential therapy regimen for Helicobacter pylori eradication. Expert Opin Pharmacother 2010;11:905-18
   PubMed Web of Science ®Google Scholar
• Vaira D, Zullo A, Vakil N, Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med 2007;146:556-63
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim SJ, Yoon JH, Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther 2011;34:1098-105
   PubMed Web of Science ®Google Scholar
• Park HG, Jung MK, Jung JT, Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients. Aliment Pharmacol Ther 2012;35:56-65
   PubMed Web of Science ®Google Scholar
• Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med 2008;148:923-31
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Ridola L, Standard triple and sequential therapies for Helicobacter pylori eradication: an update. Eur J Intern Med 2012; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Romano M, Cuomo A, Gravina AG, Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010;59:1465-70
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, D'Ercole C, Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? Aliment Pharmacol Ther 2010;31:1248-9
   PubMed Web of Science ®Google Scholar
• Zullo A, De Francesco V, Vaira D. Sequential therapy for Helicobacter pylori eradication: is levofloxacin better? Gut 2011;60:1604
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Scheiman J, Abraham NS, ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008;52:1502-17
   PubMed Web of Science ®Google Scholar
• Lanza FL, Chan FK, Quigley EM, Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728-38
   PubMed Web of Science ®Google Scholar
• Morgner A, Miehlke S, Labenz J. Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers. Expert Opin Pharmacother 2007;8:975-88
   PubMed Web of Science ®Google Scholar
• Silverstein FE, Graham DY, Senior JR, Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9
   PubMed Web of Science ®Google Scholar
• Graham DY, Agrawal NM, Campbell DR, Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002;162:169-75
   PubMed Web of Science ®Google Scholar
• Rostom A, Dube C, Wells G, Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002;CD002296
   PubMedGoogle Scholar
• Lazzaroni M, Porro GB. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors. Drugs 2009;69:51-69
   PubMed Web of Science ®Google Scholar
• Ekstrom P, Carling L, Wetterhus S, Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996;31:753-8
   PubMed Web of Science ®Google Scholar
• Hooper L, Brown TJ, Elliott R, The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 2004;329:948
   PubMed Web of Science ®Google Scholar
• Scheiman JM, Yeomans ND, Talley NJ, Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006;101:701-10
   PubMed Web of Science ®Google Scholar
• van Soest EM, Valkhoff VE, Mazzaglia G, Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases. Gut 2011;60:1650-9
   PubMed Web of Science ®Google Scholar
• Barkun AN, Bardou M, Kuipers EJ, International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010;152:101-13
   PubMed Web of Science ®Google Scholar
• Targownik LE, Metge CJ, Leung S, The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology 2008;134:937-44
   PubMed Web of Science ®Google Scholar
• Yeomans ND, Tulassay Z, Juhasz L, A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338:719-26
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Karrasch JA, Szczepanski L, Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727-34
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22
   PubMed Web of Science ®Google Scholar
• Chan FK, To KF, Wu JC, Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9-13
   PubMed Web of Science ®Google Scholar
• Santarelli L, Gabrielli M, Candelli M, Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. Eur J Gastroenterol Hepatol 2003;15:975-9
   PubMed Web of Science ®Google Scholar
• Toh BH, Chan J, Kyaw T, Cutting edge issues in autoimmune gastritis. Clin Rev Allergy Immunol 2012;42:269-78
   PubMed Web of Science ®Google Scholar
• Biondo M, Field J, Toh BH, Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. J Pathol 2006;209:384-91
   PubMed Web of Science ®Google Scholar
• Landgren AM, Landgren O, Gridley G, Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011;117:1163-71
   PubMed Web of Science ®Google Scholar
• Hsing AW, Hansson LE, McLaughlin JK, Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993;71:745-50
   PubMed Web of Science ®Google Scholar
• Hirota WK, Zuckerman MJ, Adler DG, ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63:570-80
   PubMed Web of Science ®Google Scholar
• Khan S, Orenstein SR. Eosinophilic gastroenteritis. Gastroenterol Clin North Am 2008;37:333-48, v
   PubMed Web of Science ®Google Scholar
• Niemela S, Karttunen TJ, Kerola T. Treatment of Helicobacter pylori in patients with lymphocytic gastritis. Hepatogastroenterology 2001;48:1176-8
   PubMedGoogle Scholar
• Makinen JM, Niemela S, Kerola T, Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment. World J Gastroenterol 2003;9:2706-10
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, Group O. Staging gastritis: an international proposal. Gastroenterology 2005;129:1807-8
   PubMed Web of Science ®Google Scholar